Physician profile
Beth Sanabria
NPI 1700667920
$3,990.52
in general payments reported to CMS, 2019-2025
14 companies · $3,562 in 2025
The $3,562 reported for 2025 was more than what 97% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $429 · 2025: $3,562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,100 · Travel and Lodging: $1,432 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $305 · Education: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,099.80 |
| Travel and Lodging | $1,432.47 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $305.25 |
| Education | $153.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,755.02 | 2024-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Vertex Pharmaceuticals Incorporated | $385.16 | 2025 | |
| Collegium Pharmaceutical, INC. | $240.97 | 2024-2025 | Belbuca |
| Averitas Pharma INC. | $168.03 | 2024-2025 | Qutenza |
| Boston Scientific Corporation | $148.94 | 2024-2025 | Wavewriter Alpha Prime 16, Intracept |
| Electronic Waveform Lab, INC. | $88.40 | 2024-2025 | |
| Abbvie INC. | $49.39 | 2025 | |
| Fidia Pharma USA INC. | $34.07 | 2024-2025 | Triluron |
| Convatec INC. | $25.45 | 2025 | |
| Biogen, INC. | $25.28 | 2025 | Skyclarys |
| Globus Medical, INC. | $22.81 | 2025 | Senza |
| Nalu Medical, INC. | $17.65 | 2025 | Nalu Neurostimulation System |
| Idorsia Pharmaceuticals US INC | $15.50 | 2024 | Quviviq |
| International Rehabilitative Sciences, INC | $13.85 | 2025 | Rs-4i Plus With Intersperse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Sanabria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.